Belgium is currently observing a research & development by business enterprise, pharmaceutical industry in constant ppp $ of 3,355.81 million, marking a decrease of 262.09 million (-7.2%) compared to 2020.
Research & development by business enterprise, pharmaceutical industry in constant PPP $ in Belgium
No matching regions
Similar regions to Belgium
Business R&D pharmaceutical in constant PPP $
More indicators for Belgium
Government R&D in security as % of government support
0.57%
+0.04%
(2021)
Higher-education-finacing R&D financed by general university in local currency
5,852.10M
+13.15M
(2021)
R&D financed by rest of the world in local currency
26,260.79M
+4,084.35M
(2021)
Government R&D financed by rest of the world in local currency
6,925.35M
+684.87M
(2021)
Business R&D financed by rest of the world in local currency
16,271.76M
+2,762.21M
(2021)
Non-profit R&D growth rate
-8.8%
+7%
(2022)
Belgium Business R&D pharmaceutical in constant PPP $ between 1998 and 2021
| Period | Business R&D pharmaceutical in constant PPP $ | Change |
|---|---|---|
| 2021 | 3,355.81M | -262.09M |
| 2020 | 3,617.90M | +253.54M |
| 2019 | 3,364.37M | +222.52M |
| 2018 | 3,141.85M | +459.59M |
| 2017 | 2,682.26M | +175.12M |
| 2016 | 2,507.13M | +517.83M |
| 2015 | 1,989.30M | +14.32M |
| 2014 | 1,974.98M | -14.50M |
| 2013 | 1,989.48M | +12.94M |
| 2012 | 1,976.54M | +90.63M |
| 2011 | 1,885.92M | +348.92M |
| 2010 | 1,536.99M | -32.34M |
| 2009 | 1,569.33M | +0.57M |
| 2008 | 1,568.76M | +23.40M |
| 2007 | 1,545.36M | +123.69M |
| 2006 | 1,421.67M | +358.83M |
| 2005 | 1,062.84M | -68.38M |
| 2004 | 1,131.22M | +107.61M |
| 2003 | 1,023.61M | +67.91M |
| 2002 | 955.70M | -45.59M |
| 2001 | 1,001.29M | +165.18M |
| 2000 | 836.11M | -38.08M |
| 1999 | 874.18M | +112.43M |
| 1998 | 761.75M |